- Home
- SYRE vs CNOB Comparison
SYRE vs CNOB Comparison
Compare SYRE & CNOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- CNOB
- Stock Information
- Founded
- SYRE 2013
- CNOB 1982
- Country
- SYRE United States
- CNOB United States
- Employees
- SYRE N/A
- CNOB N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- CNOB Major Banks
- Sector
- SYRE Health Care
- CNOB Finance
- Exchange
- SYRE Nasdaq
- CNOB Nasdaq
- Market Cap
- SYRE 841.4M
- CNOB 892.9M
- IPO Year
- SYRE 2016
- CNOB 1996
- Fundamental
- Price
- SYRE $15.30
- CNOB $22.97
- Analyst Decision
- SYRE Buy
- CNOB Buy
- Analyst Count
- SYRE 6
- CNOB 2
- Target Price
- SYRE $55.00
- CNOB $28.00
- AVG Volume (30 Days)
- SYRE 490.0K
- CNOB 176.5K
- Earning Date
- SYRE 05-08-2025
- CNOB 07-24-2025
- Dividend Yield
- SYRE N/A
- CNOB 3.13%
- EPS Growth
- SYRE N/A
- CNOB N/A
- EPS
- SYRE N/A
- CNOB 1.84
- Revenue
- SYRE N/A
- CNOB $256,824,000.00
- Revenue This Year
- SYRE N/A
- CNOB $47.45
- Revenue Next Year
- SYRE N/A
- CNOB $30.76
- P/E Ratio
- SYRE N/A
- CNOB $12.48
- Revenue Growth
- SYRE N/A
- CNOB 1.84
- 52 Week Low
- SYRE $10.91
- CNOB $17.07
- 52 Week High
- SYRE $40.26
- CNOB $29.31
- Technical
- Relative Strength Index (RSI)
- SYRE 51.16
- CNOB 46.47
- Support Level
- SYRE $14.87
- CNOB $22.61
- Resistance Level
- SYRE $15.71
- CNOB $23.75
- Average True Range (ATR)
- SYRE 0.72
- CNOB 0.60
- MACD
- SYRE 0.10
- CNOB -0.14
- Stochastic Oscillator
- SYRE 51.57
- CNOB 26.41
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About CNOB ConnectOne Bancorp Inc.
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.